Form EFFECT Prelude Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crypto News Today: AlphaPepe Presale Announces Launch Reveal As Ethereum Price Prediction Targets $10,000
- Andersen Announces Pricing of Secondary Offering
- Frost & Sullivan: Kaspersky Recognized for Leadership in Asia-Pacific OT Cybersecurity and Converged IT/OT Security
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
